Addressing young patients' unique needs in breast cancer care

90 Просмотры

  • Спасибо! Поделитесь с друзьями!

    Вам не понравилось видео. Спасибо за то что поделились своим мнением!

admin
Издатель
Megan Tesch, MD, Dana Farber Cancer Institute, Boston, MA, comments on the importance of tailoring breast cancer treatment for patients aged 40 years or younger. Increased representation in clinical trials is essential, due to age-related differences in tumor immune microenvironments. Clinicians subsequently need to understand this population's unique challenges to improve disease management, psychosocial support, and fertility considerations for optimal outcomes. This interview took place at the 2024 San Antonio Breast Cancer Symposium (SABCS) congress in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Категория
Рак Молочной Железы
Комментариев нет.

Следующее